NCT00345137View on ClinicalTrials.gov

Effects of Systemic NO-Inhibition on Renal Hemodynamics in Patiens With Polycystic Kidney Disease and Chronic Glomerulonephritis

PHASE1CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

Not specified

Conditions
ADPKDGlomerulonephritis
Interventions
DRUG

Ng-monomethyl-L-arginine (drug)

All Listed Sponsors
lead

Regional Hospital Holstebro

OTHER

NCT00345137 - Effects of Systemic NO-Inhibition on Renal Hemodynamics in Patiens With Polycystic Kidney Disease and Chronic Glomerulonephritis | Biotech Hunter | Biotech Hunter